255.50MMarket Cap-6.07P/E (TTM)
17.310High16.650Low126.89KVolume16.800Open16.760Pre Close2.17MTurnover2.36%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High1.86P/B92.54MFloat Cap14.42052wk Low--Dividend TTM5.38MShs Float1115.000Historical High--Div YieldTTM3.94%Amplitude7.500Historical Low17.080Avg Price1Lot Size
Neurogene Stock Forum
This Will continue to drive downward. And after you finally sell your position for a loss, they will buy back. Follow the money
📊⚡️📊
NEWS
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...
No comment yet